M Holdings Securities, Inc. Humanigen, Inc Transaction History

M Holdings Securities, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 24, 2022	SELL	$1.81 - $3.97 $203,534 - $446,426	-112,450 Closed	0 $0
Q2 2021 Aug 19, 2021	BUY	$13.54 - $22.74 $210,547 - $353,607	15,550 Added 16.05%	112,450 $1.95 Million
Q1 2021 May 12, 2021	SELL	$12.91 - $23.83 $167,830 - $309,790	-13,000 Reduced 11.83%	96,900 $1.85 Million
Q4 2020 Feb 26, 2021	BUY	$7.97 - $21.66 $92,452 - $251,256	11,600 Added 11.8%	109,900 $1.92 Million
Q3 2020 Nov 16, 2020	BUY	$8.0 - $28.5 $786,400 - $2.8 Million	98,300 New	98,300 $1.05 Million

558K

Ticker HGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,661,000
Description
Humanigen, Inc., a clinical-stage biopharmaceutical company, focuses on preventing and treating an immune hyper-response called ?cytokine storm'. Lenzilumab is an antibody that binds to and neutralizes granulocyte-macrophage colony-stimulating factor (GM-CSF). The company is developing lenzilumab as a treatment for cytokine storm associated with...

Get notified when there are updates to the investment portfolio of M Holdings Securities, Inc., based on Form 13F filings with the SEC.

Stay updated on M Holdings Securities, Inc. with notifications on news.